TrialMedical oncology (Northwood, London, England)2019

Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.

Francesca De Felice et al.PubMed ↗Publisher ↗

No numbers read from the abstract.